Nicole Sweeny
Corporate Officer/Principal at KALVISTA PHARMACEUTICALS, INC.
Profile
Nicole Sweeny is currently the Chief Commercial Officer at KalVista Pharmaceuticals, Inc. Prior to her current position, she worked as the Vice President of US Marketing at Shire Plc from 2016 to 2019, Vice President-Franchise Head at Takeda Pharmaceuticals U.S.A., Inc. from 2019 to 2020, and Chief Commercial Officer at Praxis Precision Medicines, Inc. from 2020 to 2023.
She received her undergraduate degree from Boston College.
Nicole Sweeny active positions
Companies | Position | Start |
---|---|---|
KALVISTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2023-07-24 |
Former positions of Nicole Sweeny
Companies | Position | End |
---|---|---|
PRAXIS PRECISION MEDICINES, INC. | Corporate Officer/Principal | 2023-03-30 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 2020-06-30 |
SHIRE | Corporate Officer/Principal | 2018-12-31 |
Training of Nicole Sweeny
Boston College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PRAXIS PRECISION MEDICINES, INC. | Health Technology |
KALVISTA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
- Stock Market
- Insiders
- Nicole Sweeny